Dr Breck O. Parker, formerly a Strategic Development Leader for GE Healthcare-Life Sciences Consumables Division, joined the EnviroLogix team on July 1 as Vice President, Molecular Diagnostic Product Development.
Breck has a BS in Biochemistry and a PhD in Molecular Pharmacology from the University of Massachusetts. At GE, he was on an international assignment focused on the exploration of ideas for future R&D projects, technical analysis of potential acquisitions, and the generation of strategic collaborations to help commercialize new projects. He also directed the commissioning of new laboratory areas for forensics and molecular biology.
Prior to GE, Breck was the Development Manager for Whatman, where he established a new molecular biology and forensics DNA technology group and lead the invention and development of the hugely successful EasiCollect™ buccal sample collection device widely used by the FBI, state crime labs and many foreign forensics agencies. He has also held positions with Eppendorf-5 Prime as Senior Director, R&D where he focused on the development of new kits for real time PCR, sample preparation, novel thermophilic DNA polymerase discovery and application development.
Bruce Ferguson, President of EnviroLogix, commented that, "The Company was very fortunate to find a person with Breck’s professional accomplishments living in Maine and prepared to make a career change from a very large company with a global reputation to a small one whose reputation is growing in life science circles. Breck has already contributed to the growth and organization of our nucleic acid diagnostic group, and is extremely excited about the opportunity that our exclusive isothermal amplification license represents for bringing new products to market."